Acadia Healthcare (ACHC) Set to Announce Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) is expected to release its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Acadia Healthcare to post earnings of $0.4625 per share and revenue of $877.76 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 9:00 AM ET.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The firm had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. During the same period last year, the business earned $0.83 EPS. The business’s revenue was down .4% on a year-over-year basis. On average, analysts expect Acadia Healthcare to post $1.55 EPS for the current fiscal year and $1.78 EPS for the next fiscal year.

Acadia Healthcare Trading Down 0.5%

Shares of ACHC opened at $29.74 on Wednesday. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $35.83. The firm’s 50-day simple moving average is $28.94 and its 200 day simple moving average is $25.39.

Analysts Set New Price Targets

A number of research analysts have recently commented on ACHC shares. UBS Group increased their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. TD Cowen lifted their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. KeyCorp lifted their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Barclays upped their target price on Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $30.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.